Cardiovascular Diseases Clinical Trial
Official title:
Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
Patients are part of a family network. When any person in a family becomes critically unwell
and requires the assistance of an Intensive Care Unit (ICU), this has an impact on all
members of that family.
COVID-19 changed visiting for all patients in hospitals across Scotland. It is not known what
effect these restrictions will have on patients' recovery, nor do we understand the impact it
may have on their relatives or staff caring for them. This study will look at the
implications of the visiting restrictions as a consequence of the COVID-19 pandemic upon
patients without COVID-19 who are in the cardiothoracic ICU. It will also explore the impact
of these restrictions on them, their relatives and staff.
This study will be carried out within a single specialised intensive care unit in Scotland
using mixed methods.
The first arm of this study will use retrospective data that is routinely collected in normal
clinical practice. The investigators will compare patient outcomes prior to COVID-19 with
outcomes following the implementation of COVID-19 visiting restrictions. The aim is to
establish if the restrictions on visiting has an impact on the duration of delirium. Delirium
is an acute mental confusion and is associated with longer hospital stays and worse outcomes
in this patient group.
The second arm of this study involves semi-structured interviews with patients, relatives and
staff that will allow deeper exploration of the issues around current visiting policy. The
interviews will last approximately 1 hour and will address these issues. They will then be
transcribed word for word and analysed using grounded theory, meaning the theories will
develop from the data as it is analysed.
This study will look at the implications of visiting restrictions on patients without
COVID-19 who are in the intensive care unit. It will also explore the impact of these
restrictions on them, their relatives and staff.
The investigators hypothesise that the restriction of visiting has a negative impact on
recovery of patients, families of patients and staff caring for patients without COVID-19 in
the cardiothoracic ICU.
In order to answer this hypothesis, the wider implications of COVID-19 will be explored, not
only with patients, but also relatives and staff involved in the care of these patients.
The research questions this study aims to answer are:
1. Is there a negative impact on the clinical outcomes due to the COVID-19 visitation
restrictions?
2. Is there an increase in the incidence and duration of delirium in patients who do not
receive visitors?
3. What experiences do patients recall during their ICU admission through the COVID-19
pandemic visitation restrictions?
4. What experiences do relatives recall from their loved-ones during an ICU admission
during the COVID-19 pandemic visitation restrictions?
5. What impact, if any, do the changes to visiting have on staff?
In order to answer these research questions the investigators will carry out a single centre
mixed method observational study. This study will consist of two arms.
The first arm of this study will utilise retrospective data that is routinely collected in
normal clinical practice in this single centre. This will be used to compare to patient
outcomes prior to COVID-19 with outcomes following the implementation of COVID-19 visiting
restrictions.
The second arm of this study involves semi-structured interviews with patients, relatives and
staff that allow deeper exploration of the issues around current visiting policy.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|